Work

Somatic ERCC2 Mutations Confer Cisplatin Sensitivity in Muscle-Invasive Urothelial Cancer

Year: 2014

Type: article

Study design: Observational Study

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2014.05.481

Authors: K. Mouw, E. Van Allen, K. O’Connor, N. Wagle, P. Kim, H. Al-Ahmadie, C. Zhu, I. Ostravnaya, G. Iyer, S. Signoretti, V. Reuter, G. Getz, P.W. Kantoff, B. Bochner, T.K. Choueiri, D.F. Bajorin, S. Gabriel, A. D’Andrea, L. Garraway, J.E. Rosenberg

Institutions: Harvard University, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, Broad Institute, Brigham and Women's Hospital

Language: English

Topic: Bladder and Urothelial Cancer Treatments

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2122091583

FWCI:

Cites:

Cited by:

Related to: 10